Podcasts Other The Mike Hosking Breakfast Lisa Williams: Pharmac director says new lung cancer drug will benefit around 700 people each year

Lisa Williams: Pharmac director says new lung cancer drug will benefit around 700 people each year

Published: March 7, 2023, 6:48 p.m.

b'

Game-changing drugs for people with lung cancer.

\\n

Pharmac has announced its funding of Keytruda and Tecentriq.

\\n

Those with locally advanced and metastatic non-small cell lung cancer are able to access it from next month.

\\n

The disease is the leading cause of cancer-related deaths in New Zealand.

\\n

Director of operations Lisa Williams told Mike Hosking there hasn\'t been treatment for lung cancer in New Zealand like this.

\\n

She says they\'re a new kind of immune checkpoint inhibitors, which will benefit around 700 people each year.

\\n

LISTEN ABOVE

\\n

\\xa0

See omnystudio.com/listener for privacy information.

'